RXO · RXO, Inc.

The thesis

RXO, Inc. trades as the target of a pending takeover, and the shares are pinned to the deal value rather than to freight conditions. C.H. Robinson agreed on 5 October 2026 to pay $17.25 in cash plus 0.0856 C.H. Robinson shares per RXO share, an implied $30.25 at announcement. Regulatory and shareholder approval, expected in the first half of 2027, settles the outcome.

The last close, on 26 October 2026, was $28.68, against a 52-week high of $29.30. The shares are up 28.7% over three months, nearly all of it from the announcement. Analyst targets of $30 to $30.25 sit at or below the implied offer, so the case offers little room above the terms.

The narrative is saturated: the deal was announced three weeks ago, five brokers reset targets to the offer by 7 October 2026, and the latest news item is a 19 October 2026 Benzinga list of overbought industrials. The 14-day relative strength index (RSI) has since fallen to 52.3 on adjusted daily closes, from 89.5 on 13 October 2026. That points to cooling momentum, not to new doubts about the deal. The next two dated events are C.H. Robinson's third-quarter report and RXO's own.

Bullish and bearish views on RXO, Inc.

The bull case on RXO, Inc. (RXO), in brief: A signed deal at a premium. The bear case: Little room above the offer.

Bull case

• A signed deal at a premium. The 5 October 2026 merger release values RXO at $5.8 billion, or $30.25 per share. That was a 29% premium to the 2 October 2026 close and 27% to the 90-day volume-weighted average price.
• Most of the price is cash. About 57% of the consideration is cash and 43% is C.H. Robinson stock, per the merger release. Holders may elect all cash at $30.25 or all stock at 0.1992 shares, subject to proration.
• The largest holder is committed. MFN Partners, with about 17% of RXO, signed a voting agreement to support the merger, per the 5 October 2026 release.
• Financing is committed. C.H. Robinson will fund the cash with new debt backed by a fully underwritten Morgan Stanley Senior Funding bridge facility, per the same release.
• The business was improving before the deal. Second-quarter 2026 adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $40 million against guidance of $27–37 million, per the 6 August 2026 release. August truckload gross profit per load rose more than 10% from July, per the 9 September 2026 Form 8-K.

Bear case

• Little room above the offer. JPMorgan, Citigroup, Wells Fargo and Truist set $30 targets and TD Cowen set $30.25, between 6 October 2026 and 7 October 2026, per Benzinga. None is above the implied deal value.
• The stock part floats. The $30.25 figure used C.H. Robinson's 16-day volume-weighted average price of $151.88 as of 2 October 2026. Robinson's price each day.
• A long wait to close. The companies target the first half of 2027. Both antitrust review of two large US freight brokers and an RXO shareholder vote are still ahead, and no filing in the record sets a date for either.
• Freight costs are rising. Benzinga reported on 16 September 2026 that diesel was up 70% over the past year and that J.B. Hunt fell 13% that day on a third-quarter profit warning.
• Share price sits below the offer. The 26 October 2026 close of $28.68 is under the $30.25 announcement value. The gap is the market's price for time and for the risk of failure or a lower C.H. Robinson share price.

Price setup

Benzinga reported RXO up 21.68% intraday on 5 October 2026, the day of the announcement. Adjusted daily closes put the 26 October 2026 close at $28.68, which is 2.1% below the 52-week high of $29.30.

The shares have traded in a narrow range near the offer since the announcement. The RSI reading of 52.3 on 26 October 2026 shows the post-announcement surge has cooled. Upside is limited by the $30.25 announcement value unless C.H. Robinson's shares rise or the terms improve.

Crowding evidence is thin. No filings or insider transactions are in the recent record, and the only recent news is analyst target resets and momentum lists. Two earnings dates fall within the next two weeks.

Catalysts, next 30 days

• ~5 November 2026, est.: RXO third-quarter 2026 report. The date is a MarketBeat estimate and RXO has not confirmed it in any source found. The report tests the $35–45 million adjusted EBITDA guidance issued on 6 August 2026.
• Later, ~30 June 2027, est.: expected close. Regulatory and shareholder approvals decide whether the shares convert to $30.25 of mixed consideration at the announced terms.

Elapsed catalysts

• ~29 October 2026, est.: C.H. Robinson third-quarter 2026 report. Its share price sets the value of the stock part of the offer, and management may update the merger timeline. The date is an estimate. (passed 2d ago)

What would change the view

The case breaks if the merger agreement is terminated, if its terms are cut, or if regulators extend or challenge the review. A Form 8-K reporting any of those would end it. A second request for information from antitrust authorities, disclosed in a merger filing, would push the closing past the first-half-2027 target.

On price, a daily close below $25 would sit far under the $30.25 implied value and show the market doubts the deal closes. Third-quarter adjusted EBITDA below the $35 million guidance floor would also weaken the standalone value that supports the terms. A sustained rise in C.H. Robinson's shares above the $151.88 reference would raise the stock component's value and lift the implied offer.

What it trades with

RXO's price now follows C.H. Robinson's share price through the 0.0856-share component, and it follows deal-completion odds more than the freight cycle. Peers such as J.B. Hunt, which fell 13% on 16 September 2026 on a profit warning, still show the cost pressure facing the freight group. The effect on RXO is limited while the cash portion and the deal terms anchor the price. Broad equity moves matter less than merger news for this name.